Joy Bessenger
Director of Finance/CFO at TRELLUS HEALTH PLC
Joy Bessenger active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRELLUS HEALTH PLC | Director of Finance/CFO | 2023-09-17 | - |
Career history of Joy Bessenger
Former positions of Joy Bessenger
| Companies | Position | Start | End |
|---|---|---|---|
| IMV INC. | Investor Relations Contact | 2021-08-31 | 2022-06-10 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Public Communications Contact | 2009-06-25 | - |
Training of Joy Bessenger
| University of South Florida | Undergraduate Degree |
Statistics
International
| Iceland | 2 |
| Canada | 2 |
| United States | 2 |
Operational
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| IMV INC. | Health Technology |
| TRELLUS HEALTH PLC | Technology Services |
| Private companies | 1 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Stock Market
- Insiders
- Joy Bessenger
- Experience
